Overview

Safety and Efficacy Study of Ceftaroline in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia

Status:
Completed

Trial end date:
2014-07-01

Target enrollment:

Participant gender:

Summary

This is a study of safety and efficacy of ceftaroline fosamil in Subjects with Staphylococcus aureus Bacteremia or with Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia persisting after at least 72 hours of vancomycin and/or daptomycin treatment.

Phase:

Phase 4

Details

Lead Sponsor:

Forest Laboratories

Treatments:

Ceftaroline fosamil
Cephalosporins
Methicillin